http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-161319-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-89
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-65
filingDate 1983-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd33f85506074b073ab73a2df306aa93
publicationDate 1989-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-161319-B
titleOfInvention ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE IMIDAZO (1,5-A) PYRIDINE DERIVATIVES.
abstract Novel imidazo [1,5-a] pyridine derivatives of formula I. or their 5,6,7,8-tetrahydro derivatives ,. which means hydrogen,. halogen, lower alkyl,. lower alkoxy, hydroxy. or aryl lower alkoxy,. wherein aryl is phenyl or with lower alkoxy, lower alkyl, halogen or trifluoromethyl mono- or di-substituted phenyl, R represents hydrogen, halogen or lower lower alkyl, C means carboxy, lower. alkoxy carbonyl, unsubstituted, mono- or di-lower alkyl-substituted carbamoyl, cyano, formyl ,. hydroxymethyl, 5-tetrazolyl, unsubstituted or. with lower alkyl substituted 4,5-dihydro-2-oxazolyl, or hydroxycarbamoyl, and. (a) A means unsubstituted or lower alkyl. substituted ethenylene (vinylene) and B means alkylene. with 1-12 C atoms, alkinylene or alkenylene with. 2-12 C atoms, phenylene-lower alkylene, phenylene-lower alkylene, phenylene, phenylene- (thio or oxy) -lower alkylene, or (b) A means a bond and B means lower alkylene-. phenylene, phenylene-lower alkylene, phenylene, lower alkylene- (thio or oxy) -lower alkylene, lower alkylene- (thio or oxy) -phenylene, phenylene- (thio or oxy) -lower alkylene, phenylene-lower alkylene, lower alkylene The invention further relates to the process for the preparation of these compounds, their use and to pharmaceutical compositions containing these compounds. .
priorityDate 1982-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID274090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455585947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409708697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456357891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 48.